Trial Outcomes & Findings for Visual Performance Investigation of Two Toric Soft Contact Lenses (NCT NCT01858701)
NCT ID: NCT01858701
Last Updated: 2014-10-22
Results Overview
Ocular coma is a type of optical aberration or a distortion in image formation occurring when a bundle of light rays enters an optical system (eye) that is not parallel to the optic axis. Ocular coma will be measured in micrometers using a Ladarwave aberrometer. A lower number indicates less coma/less image distortion. One eye (right eye) contributed to the mean.
COMPLETED
NA
49 participants
Day 30
2014-10-22
Participant Flow
Participants were recruited from 1 study center located in Canada.
Of the 49 enrolled, 9 participants were exited as screen failures prior to randomization. This reporting group includes all randomized participants (40).
Participant milestones
| Measure |
AO for Astig / Biofinity Toric
Lotrafilcon B toric contact lenses worn in Period 1, followed by comfilcon A toric contact lenses in Period 2.
|
Biofinity Toric / AO for Astig
Comfilcon A toric contact lenses worn in Period 1, followed by lotrafilcon B toric contact lenses in Period 2.
|
|---|---|---|
|
Period 1, First 30 Days of Wear
STARTED
|
20
|
20
|
|
Period 1, First 30 Days of Wear
COMPLETED
|
20
|
19
|
|
Period 1, First 30 Days of Wear
NOT COMPLETED
|
0
|
1
|
|
Washout Period, 1-13 Days
STARTED
|
20
|
19
|
|
Washout Period, 1-13 Days
COMPLETED
|
18
|
17
|
|
Washout Period, 1-13 Days
NOT COMPLETED
|
2
|
2
|
|
Period 2, Second 30 Days of Wear
STARTED
|
18
|
17
|
|
Period 2, Second 30 Days of Wear
COMPLETED
|
18
|
16
|
|
Period 2, Second 30 Days of Wear
NOT COMPLETED
|
0
|
1
|
Reasons for withdrawal
| Measure |
AO for Astig / Biofinity Toric
Lotrafilcon B toric contact lenses worn in Period 1, followed by comfilcon A toric contact lenses in Period 2.
|
Biofinity Toric / AO for Astig
Comfilcon A toric contact lenses worn in Period 1, followed by lotrafilcon B toric contact lenses in Period 2.
|
|---|---|---|
|
Period 1, First 30 Days of Wear
Withdrawal by Subject
|
0
|
1
|
|
Washout Period, 1-13 Days
Inclusion/Exclusion Criteria Not Met
|
1
|
0
|
|
Washout Period, 1-13 Days
Withdrawal by Subject
|
1
|
2
|
|
Period 2, Second 30 Days of Wear
Comfort
|
0
|
1
|
Baseline Characteristics
Visual Performance Investigation of Two Toric Soft Contact Lenses
Baseline characteristics by cohort
| Measure |
Overall
n=49 Participants
Lotrafilcon B toric contact lenses and comfilcon A toric contact lenses worn during Period 1 and Period 2 in a crossover assignment.
|
|---|---|
|
Age, Continuous
|
28 years
STANDARD_DEVIATION 8.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
36 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day 30Population: This analysis population includes all participants who completed the study.
Ocular coma is a type of optical aberration or a distortion in image formation occurring when a bundle of light rays enters an optical system (eye) that is not parallel to the optic axis. Ocular coma will be measured in micrometers using a Ladarwave aberrometer. A lower number indicates less coma/less image distortion. One eye (right eye) contributed to the mean.
Outcome measures
| Measure |
Air Optix for Astig
n=34 Participants
Lotrafilcon B toric contact lenses worn bilaterally on a daily wear basis (removed nightly) during Period 1 or Period 2, for 30 days.
|
Biofinity Toric
n=34 Participants
Comfilcon A toric contact lenses worn bilaterally on a daily wear basis (removed nightly) during Period 1 or Period 2, for 30 days.
|
|---|---|---|
|
Mean Ocular Coma Score at 5mm Pupil at Day 30
|
0.16 micrometers
Standard Deviation 0.09
|
0.24 micrometers
Standard Deviation 0.11
|
Adverse Events
Air Optix for Astig
Biofinity Toric
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER